Monday, September 25, 2017
Company News: Page (1) of 1 - 09/14/17 Email this story to a friend. email article Print this page (Article printing at page facebook
The Prostate Cancer Foundation, in Collaboration With World's Leading Researchers, Publish Standard Setting Comprehensive Patient Guide
Guide Offers Recommendations on Newest Life-Extending Treatments for Men with Metastatic Prostate Cancer and their Families
(September 14, 2017)

LOS ANGELES, Sept. 14, 2017 /PRNewswire-USNewswire/ -- The Prostate Cancer Foundation, in honor of Prostate Cancer Awareness Month this September, today released the Prostate Cancer Patient Guide, a new, comprehensive health guide for prostate cancer patients, of whom there are estimated to be three million in the United States. The 36-page patient guide, available for download at, was compiled using the expertise from doctors and researchers from leading cancer institutes around the United States including: University of Michigan, Duke University, University of Washington, Fred Hutchinson Cancer Research Center, University of California Los Angeles, New York University, Northwestern University, Dana Farber Cancer Institute and Harvard Medical School.

Visit (PRNewsFoto/Prostate Cancer Foundation) (PRNewsFoto/Prostate Cancer Foundation)

Unlike previous patient resources, the Prostate Cancer Patient Guide is geared not just towards patients and caregivers, but the whole family. It provides helpful in-depth information for navigating a prostate cancer, offering details on the most up-to-date life-extending treatments for men with metastatic prostate cancer. The guide also introduces precision medicine as a tool for curing patients and families across all cancer types.

"PCF research is increasingly revealing the genetic underpinnings of cancer across cancer types," said Prostate Cancer Foundation President & CEO Jonathan Simons, M.D. "Family members must take the time to understand how genes that run in families can affect their health.  This is not just for men - and not just for prostate cancer - but for all men and women and sons and daughters and grandchildren in the family. And it goes across all cancer types."

The guide is provided for free in both digital and printed copy. Prostate cancer patient and former Washington Post reporter Bill Curry said, "Today's cancer decision making is an obstacle course. I wish there had been something like this 10 years ago when I was diagnosed: a one-place go-to to foster a meaningful discussion with a doctor. Thanks to the PCF, there's so much more knowledge out there today to factor in and absorb."

About the Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $700 million and provided funding to more than 2,000 research programs at more than 200 cancer centers and universities. The PCF global research enterprise now extends to 19 countries and funds a robust research portfolio. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer. For more information, visit

Christina Witz
Group Director, W2O Group
[email protected]

View original content with multimedia:

SOURCE Prostate Cancer Foundation

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:Science, Medical, Biology, Genetics, Cancer, Family, Men, Women,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • The High-Tech Future of Home Healthcare
  • A Medical Implants Manufacturer Used Salesforce Effectiveness Solution to Improve Salesforce Performance Provided by Quantzig
  • Point of Care Technology Market :Company information, geographical data and Market Analysis
  • Dental Market Trends, Size, Growth, Leading Players, Opportunities and 2021 Global Analysis Forecasts Discussed in New Research Report
  • Human Genetics Market Dynamics, Comprehensive Analysis, Business Growth, Prospects and Opportunities 2016-2024

  • Targovax granted US Patent for mutant-RAS neoantigen platform lead products
  • Hammertoe Market US $ 450 Million Acquire A Massive Growth By 2023
  • Hammertoe Market US $ 450 Million Acquire A Massive Growth By 2023
  • Crux Quality Solutions To Exhibit And Demo Workflow Automation Tool, FlowBoard At ASTRO 2017 Annual Meeting
  • Elekta and Brainlab Collaborate to Streamline Treatment Workflows for Stereotactic Radiation Therapy

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines